Location: Munich, Germany
Date: September 12 to September 16
52nd EASD Annual Meeting.
Highlights from the EASD 2016
Novelties and new highlights in diabetes therapy
A decade of DPP-4 inhibition: What have we learned?
Highlights of the Congress
What's new in type-2 diabetes therapy? Diabetes drugs of the future.
Overall interview about: Messages of TECOS study, SGLT-2 inhibitors and their therapeutic options, and managing diabetes.
Kidney complications and novelties in this field.
Public Health Challenges